JNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

The Ministry of Health has conceded a shortage of vaccines for newborns. The Director General for Health Patrick Amoth on ...